Tore Kristian Kvien

46PUBLICATIONS
181CO-AUTHORS
Reinforcement learningApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisMajor global burdens of diseaseGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Apr 06, 2026
Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration.

Zubeyir Salis, Denis Mongin, Denis Choquette

|Mar 19, 2026
Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Teresa Holly, Marthe Kirkesaether Brun, Kristin Kaasen Jørgensen

|Dec 02, 2025
Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis.

Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen

|Nov 06, 2025
NSAID Use, Gastrointestinal Complications, and Burden of Disease in Osteoarthritis: Nordic Registry Study with Emphasis on Patients Below 60 Years.

Tore K Kvien, Johan L Hansen, Robert Böttger

|Jun 05, 2025
Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings.

Tore K Kvien, Neil Betteridge, Ines Brückmann

|Apr 28, 2025
Three-Year Results of Tapering Tumor Necrosis Factor Inhibitor to Withdrawal Compared to Stable Tumor Necrosis Factor Inhibitor Among Patients With Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial.

Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga

Pageof 8

Frequent Collaborators

10 joint publications

Sella Provan

10 joint publications

Till Uhlig

10 joint publications

Florenzo Iannone

8 joint publications

Bente Glintborg